Page last updated: 2024-08-26

prolinedithiocarbamate and T-Cell Lymphoma

prolinedithiocarbamate has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Alessandro, N; Dusonchet, L; Meli, M; Notarbartolo, M; Rausa, L; Tolomeo, M1

Other Studies

1 other study(ies) available for prolinedithiocarbamate and T-Cell Lymphoma

ArticleYear
NF-kappaB inhibition restores sensitivity to Fas-mediated apoptosis in lymphoma cell lines.
    Annals of the New York Academy of Sciences, 2003, Volume: 1010

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; fas Receptor; Humans; Leupeptins; Lymphoma, T-Cell; NF-kappa B; Peptides; Proline; Thiocarbamates

2003